nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement to Referees
|
|
|
|
46 |
6 |
p. 707-709 |
artikel |
2 |
Advances in Thiopurine Drug Delivery: The Current State-of-the-Art
|
Bayoumy, Ahmed B. |
|
|
46 |
6 |
p. 743-758 |
artikel |
3 |
A Systematic Review of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid Area Under the Concentration–Time Curve Estimation
|
Sobiak, Joanna |
|
|
46 |
6 |
p. 721-742 |
artikel |
4 |
Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
|
Kareva, Irina |
|
|
46 |
6 |
p. 827 |
artikel |
5 |
Generic Drug Product Development in Japan: Regulatory Updates During 2014–2019 and the Future
|
Kasuga, Miho |
|
|
46 |
6 |
p. 711-719 |
artikel |
6 |
Oral Antibiotics in Patients with Short Bowel Syndrome: Do or Don’t?
|
Gompelman, Michelle |
|
|
46 |
6 |
p. 821-823 |
artikel |
7 |
Oral Antibiotics in Patients with Short Bowel Syndrome: Hurdles and Caveats
|
Law, Lawrence Siu-Chun |
|
|
46 |
6 |
p. 825-826 |
artikel |
8 |
Pharmacokinetic Properties of S-oxiracetam After Single and Multiple Intravenous Infusions in Healthy Volunteers
|
Liang, Dahu |
|
|
46 |
6 |
p. 793-805 |
artikel |
9 |
Pharmacokinetics of Synthetic Cathinones Found in Bath Salts in Mouse Brain and Plasma Using High-Pressure Liquid Chromatography–Tandem Mass Spectrometry
|
Gearlds, Courtney |
|
|
46 |
6 |
p. 771-778 |
artikel |
10 |
Pharmacokinetics, Tolerability, and Safety of Single and Multiple Omecamtiv Mecarbil Doses in Healthy Japanese and Caucasian Subjects
|
Trivedi, Ashit |
|
|
46 |
6 |
p. 759-770 |
artikel |
11 |
Physiologically-Based Pharmacokinetic Modelling of Entrectinib Parent and Active Metabolite to Support Regulatory Decision-Making
|
Djebli, Nassim |
|
|
46 |
6 |
p. 779-791 |
artikel |
12 |
Population Pharmacokinetic Analysis from First-in-Human Data for HDAC Inhibitor, REC-2282 (AR-42), in Patients with Solid Tumors and Hematologic Malignancies: A Case Study for Evaluating Flat vs. Body Size Normalized Dosing
|
Liva, Sophia |
|
|
46 |
6 |
p. 807-816 |
artikel |
13 |
Severe 5-Fluorouracil-Associated Gastrointestinal Toxicity Unexplained by Dihydropyrimidine Dehydrogenase Deficiency and Renal Impairment: Should We Be Investigating Other Elimination Pathways to Assess the Risk of 5-Fluorouracil Toxicity?
|
Jeong, Soo Hee |
|
|
46 |
6 |
p. 817-820 |
artikel |